LOADING
Comparing Microsoft Corporation (MSFT) and Eli Lilly and Company (LLY) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | LLY |
|---|---|---|
| Price | $423.52 | $1,008.87 |
| Change Today | +3.44% | +0.22% |
| Market Cap | $3.01T | $905.8B |
| P/E Ratio | 24.1 | 35.2 |
| Forward P/E | 21.5 | 26.3 |
| PEG Ratio | 1.29 | 1.28 |
| EPS | $16.78 | $28.85 |
| Revenue Growth (YoY) | 18.3% | 55.5% |
| Profit Margin | 39.3% | 35.0% |
| Return on Equity | 34.0% | 107.5% |
| Dividend Yield | 0.87% | 0.63% |
| Beta | 1.09 | 0.48 |
| 52-Week High | $552.24 | $1,132.06 |
| 52-Week Low | $356.28 | $620.46 |
| Volume | 371K | 21K |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Microsoft Corporation offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.